Shin et al. also found that TLE4 deficiency and AML1-ETO expression synergistically induced AML (Shin et al., 2016) and that loss of TLE4 induced resistance to chemotherapy in AML cell lines by activating the Wnt signaling pathway (Shin et al., 2016). This evidence concerns the gene RUNX1 and acute myeloid leukemia.